Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

002287.SZ

HOLDREMOVE

Tibet Cheezheng Tibetan Medicine Co., Ltd. · Healthcare · China · $1.8B · Avg Vol: $5M/d

60
StockRank
Q
67
V
44
M
38
P/E (TTM)
16.8x
ROE
14.6%
D/E
0.2x
Dividend %
2.0%
AI CONVICTION THESIS

Tibet Cheezheng Tibetan Medicine manufactures traditional Chinese medicines. It is a localized consumer healthcare business with zero exposure to our global macro themes and faces regulatory and geopolitical risks within the domestic Chinese market.

COMPANY DESCRIPTION

Tibet Cheezheng Tibetan Medicine Co., Ltd. researches, develops, and manufactures traditional Tibetan medicines, with its flagship pain-relief plaster holding a dominant market share in China's external analgesic market. The company's competitive moat is secured by proprietary national-level secret formulas and exclusive access to high-altitude medicinal herbs from the Tibetan Plateau. It operates as a highly profitable niche leader with strong brand equity and pricing power.

FINANCIAL SUMMARY

Year2022202320242025CAGR
Revenue302M302M346M357M5.7%
EPS0.130.160.160.1810.2%
Shares530M530M531M572M+7.9%
Debt251M227M251M137M-18.2%
Equity493M550M601M731M14.0%
Op CF42M102M68M108M36.7%
Inv CF-49M-46M-77M3M
Fin CF-27M-64M-20M-83M
Loading...
PRICE (1M)-9.5%
2.953.073.183.293.40Apr 30May 26Jun 15
SMA 50SMA 200
Close
$3.04
RSI (14)
39.1
52W High
$5.59
From 52W High
0.5%

SCORE BREAKDOWN

Quality
67
ROIC
14.9%84.9
ROE
14.6%82.1
GP/Assets
29.3%63.9
Op. Margin
22.2%85.3
FCF/Assets
-3.2%40.1
Piotroski
55.8
Int. Cover
18.7x74.2
D/E Ratio
0.16x57.2
Current Ratio
3.12x54.5
Value
44
P/E (TTM)
16.8x66.9
EV/EBITDA
13.4x31.9
P/FCF
N/A
P/B
2.3x49.7
P/S
4.9x42.3
Div Yield
2.0%50.8
Momentum
38
52W High %
54%29.0
RS 6M
-26%47.2
SMA 50/200
0.90x35.5
EPS Rev 4W
N/A
EPS Rev 12W
N/A
EPS Improve
-15%16.1
Q Growth
26%66.6

FUNDAMENTALS

Market Cap
$1.8B
P/E (Forward)
19.7x
Gross Margin
83.4%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 002287.SZ are excluded.

TickerCompanyMkt CapStockRankSignal
002287.SZTibet Cheezheng Tibetan Medicine Co., Ltd.(you)$1.8B60HOLD
000990.SZChengzhi Co., Ltd.$1.7B63HOLD
002030.SZDaan Gene Co., Ltd.$1.5B57HOLD
2315.HKBiocytogen Pharmaceuticals (Beijing) Co., Ltd.$2.8B61HOLD
688513.SSChengdu Easton Biopharmaceuticals Co., Ltd.$1.4B55HOLD
688253.SSInnovita Biological Technology Co., Ltd.$1.1B58HOLD
688105.SSNanjing Vazyme Biotech Co., Ltd$1.1B63HOLD
605116.SSAurisco Pharmaceutical Co.,Ltd.$1.2B56HOLD
688222.SSHitGen Inc.$1.8B47HOLD
600201.SSJinyu Bio-technology Co., Ltd.$1.9B48HOLD

Peer medians: ROE 4.7% · P/E 27.9x · Gross margin 53.0%

Tibet Cheezheng Tibetan Medicine Co., Ltd. (002287.SZ) — Stock Score Summary

Tibet Cheezheng Tibetan Medicine Co., Ltd. (002287.SZ) has a MoatMap StockRank of 60/100 based on Quality (67/100), Value (44/100), and Momentum (38/100) factor scores. The current signal is HOLD. Tibet Cheezheng Tibetan Medicine manufactures traditional Chinese medicines. It is a localized consumer healthcare business with zero exposure to our global macro themes and faces regulatory and geopolitical risks within the domestic Chinese market.

Tibet Cheezheng Tibetan Medicine Co., Ltd. researches, develops, and manufactures traditional Tibetan medicines, with its flagship pain-relief plaster holding a dominant market share in China's external analgesic market. The company's competitive moat is secured by proprietary national-level secret formulas and exclusive access to high-altitude medicinal herbs from the Tibetan Plateau. It operates as a highly profitable niche leader with strong brand equity and pricing power.

Key Financial Metrics

Price$3.04
Market Cap$1.8B
P/E (TTM)16.82
P/E (Forward)19.73
Price/Book2.31
Return on Equity14.6%
Return on Invested Capital14.9%
Debt/Equity15.88
Gross Margin83.4%
Operating Margin22.2%
Revenue Growth0.6%
Dividend Yield2.0%
Free Cash Flow$-5M

Tibet Cheezheng Tibetan Medicine Co., Ltd. operates in the Biotechnology industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is Tibet Cheezheng Tibetan Medicine Co., Ltd.’s (002287.SZ) StockRank?
MoatMap’s StockRank for Tibet Cheezheng Tibetan Medicine Co., Ltd. (002287.SZ) is 60/100, with a Hold signal. It is a composite of Quality (67), Value (44), and Momentum (38) factor ranks across MoatMap’s 19,000+ stock universe.
Does Tibet Cheezheng Tibetan Medicine Co., Ltd. have an economic moat?
Tibet Cheezheng Tibetan Medicine Co., Ltd. (002287.SZ) has a Quality factor score of 67/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Tibet Cheezheng Tibetan Medicine Co., Ltd. a buy, hold, or sell?
MoatMap’s current signal for Tibet Cheezheng Tibetan Medicine Co., Ltd. (002287.SZ) is Hold, based on a StockRank of 60/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Tibet Cheezheng Tibetan Medicine Co., Ltd. in?
Tibet Cheezheng Tibetan Medicine Co., Ltd. (002287.SZ) operates in the Healthcare sector, specifically the Biotechnology industry (China).